Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flavonoids | 2 | 2020 | 22 | 1.000 |
Why?
|
| Glucuronides | 5 | 2017 | 28 | 0.990 |
Why?
|
| Glucuronosyltransferase | 4 | 2022 | 30 | 0.760 |
Why?
|
| Hydroxyl Radical | 1 | 2020 | 3 | 0.660 |
Why?
|
| Serum Albumin, Bovine | 1 | 2020 | 20 | 0.660 |
Why?
|
| Diarrhea | 3 | 2024 | 23 | 0.480 |
Why?
|
| Rats, Inbred F344 | 2 | 2024 | 21 | 0.440 |
Why?
|
| Flavonols | 2 | 2010 | 2 | 0.430 |
Why?
|
| Animals | 12 | 2024 | 1817 | 0.390 |
Why?
|
| Isoenzymes | 1 | 2011 | 11 | 0.360 |
Why?
|
| Mouth Neoplasms | 2 | 2021 | 8 | 0.350 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2010 | 5 | 0.350 |
Why?
|
| Flavones | 1 | 2010 | 5 | 0.340 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2024 | 68 | 0.330 |
Why?
|
| Camptothecin | 2 | 2024 | 10 | 0.270 |
Why?
|
| Liver | 2 | 2021 | 51 | 0.250 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2024 | 10 | 0.250 |
Why?
|
| Feces | 1 | 2024 | 26 | 0.220 |
Why?
|
| Glycosyltransferases | 1 | 2024 | 4 | 0.220 |
Why?
|
| Chromatography, Liquid | 3 | 2024 | 38 | 0.220 |
Why?
|
| Biological Availability | 2 | 2021 | 14 | 0.200 |
Why?
|
| Glucuronidase | 1 | 2022 | 7 | 0.190 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2022 | 4 | 0.190 |
Why?
|
| Rats | 5 | 2024 | 251 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 20 | 0.190 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 242 | 0.190 |
Why?
|
| Phytochemicals | 1 | 2021 | 3 | 0.180 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2021 | 14 | 0.180 |
Why?
|
| Intestine, Small | 1 | 2021 | 6 | 0.180 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 12 | 0.180 |
Why?
|
| Phenols | 1 | 2021 | 14 | 0.180 |
Why?
|
| Magnolia | 1 | 2020 | 4 | 0.170 |
Why?
|
| Carcinoma | 1 | 2020 | 3 | 0.170 |
Why?
|
| Mice | 5 | 2024 | 719 | 0.170 |
Why?
|
| Plant Extracts | 1 | 2020 | 20 | 0.170 |
Why?
|
| Cattle | 1 | 2020 | 20 | 0.170 |
Why?
|
| Dinoprostone | 1 | 2017 | 7 | 0.140 |
Why?
|
| Colon | 1 | 2017 | 8 | 0.140 |
Why?
|
| Intestinal Mucosa | 2 | 2024 | 27 | 0.140 |
Why?
|
| Male | 6 | 2024 | 2765 | 0.130 |
Why?
|
| Uridine Diphosphate | 2 | 2024 | 5 | 0.100 |
Why?
|
| Humans | 5 | 2024 | 5476 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2011 | 17 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 24 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2010 | 87 | 0.080 |
Why?
|
| Genistein | 1 | 2010 | 5 | 0.080 |
Why?
|
| Microsomes | 1 | 2009 | 6 | 0.080 |
Why?
|
| Flavanones | 1 | 2009 | 2 | 0.080 |
Why?
|
| Microsomes, Liver | 1 | 2009 | 15 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 195 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 350 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2021 | 35 | 0.070 |
Why?
|
| Quinolines | 2 | 2021 | 21 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2021 | 31 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2021 | 85 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2024 | 26 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2024 | 14 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 53 | 0.050 |
Why?
|
| Plants | 1 | 2024 | 26 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2017 | 44 | 0.050 |
Why?
|
| Female | 2 | 2024 | 2811 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 71 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2022 | 5 | 0.050 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2022 | 5 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 9 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2022 | 12 | 0.050 |
Why?
|
| Pterocarpans | 1 | 2021 | 3 | 0.050 |
Why?
|
| Chemoprevention | 1 | 2021 | 3 | 0.050 |
Why?
|
| Quinolizines | 1 | 2021 | 5 | 0.050 |
Why?
|
| Alkaloids | 1 | 2021 | 9 | 0.050 |
Why?
|
| Benzofurans | 1 | 2021 | 6 | 0.050 |
Why?
|
| Lignans | 1 | 2020 | 5 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2020 | 8 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2020 | 8 | 0.040 |
Why?
|
| Isotope Labeling | 1 | 2017 | 3 | 0.030 |
Why?
|
| Pharmacokinetics | 1 | 2017 | 3 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2017 | 13 | 0.030 |
Why?
|
| Biological Assay | 1 | 2017 | 33 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 14 | 0.030 |
Why?
|
| Inflammation | 1 | 2017 | 59 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 87 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 136 | 0.030 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2010 | 2 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 6 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 7 | 0.020 |
Why?
|
| Dipyridamole | 1 | 2009 | 1 | 0.020 |
Why?
|
| Leukotriene Antagonists | 1 | 2009 | 1 | 0.020 |
Why?
|
| Propionates | 1 | 2009 | 3 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2009 | 2 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 10 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 19 | 0.020 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2009 | 8 | 0.020 |
Why?
|
| Intestines | 1 | 2009 | 15 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2009 | 78 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 131 | 0.020 |
Why?
|